LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Identification of Key Features of CNS Drugs Based on SVM and Greedy Algorithm.

Photo from wikipedia

INTRODUCTION The research and development of drugs related to central nervous system (CNS) diseases is a long and arduous process with high cost, long cycle and low success rate. Identification… Click to show full abstract

INTRODUCTION The research and development of drugs related to central nervous system (CNS) diseases is a long and arduous process with high cost, long cycle and low success rate. Identification of key features based on available CNS drugs is of great significance for the discovery of new drugs. MATERIALS AND METHODS In this paper, based on the PaDEL descriptors of CNS drugs and non-CNS drugs, a support vector machine (SVM) model was constructed to identify the key features of CNS drugs. Firstly, the random forest algorithm was used to rank descriptors according to the feature significance that contributes to the identification of CNS drugs. Then, a reliable SVM model was constructed, and the optimal combination of descriptors was determined based on greedy algorithm and recursive feature elimination method. RESULTS AND CONCLUSION It was found, based on the optimal combination of 40 descriptors, the prediction accuracy of CNS drugs and non-CNS drugs reached 94.2% and 94.4% respectively. nF11HeteroRing, AATSC3v, SpMin6_Bhi, maxdssC, AATS4v, E1v, E3e, GATS5s, minsOH and minHBint4 are the key features to distinguish between CNS drugs and non-CNS drugs.

Keywords: identification key; key features; cns; features cns; cns drugs

Journal Title: Current computer-aided drug design
Year Published: 2019

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.